AUB
IBRX icon

Atlantic Union Bankshares’s ImmunityBio IBRX Stock Holding History

Atlantic Union Bankshares’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.3K Buy
1,062
+680
+178% +$5.15K ﹤0.01% 1349
2026
Q1 		$2.93K Hold
382
– – ﹤0.01% 1507
2025
Q4 		$757 Hold
382
– – ﹤0.01% 1589
2025
Q3 		$940 Sell
382
-382
-50% -$984 ﹤0.01% 1530
2025
Q2 		$2.02K Buy
+764
New +$2.05K ﹤0.01% 1085

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Atlantic Union Bankshares's IBRX Position: Q2 2026 in Review

Atlantic Union Bankshares increased its ImmunityBio (IBRX) stake by 178% in Q2 2026, buying an estimated $5.15K and bringing the position to 1,062 shares worth $9.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1349.

Atlantic Union Bankshares first reported a position in IBRX in Q2 2025 and has held it in 5 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Atlantic Union Bankshares held 1,062 shares of ImmunityBio worth $9.3K as of Q2 2026.
  • Atlantic Union Bankshares bought 680 ImmunityBio shares in Q2 2026, an estimated $5.15K.
  • ImmunityBio made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q2 2026, its #1349 holding.
  • Atlantic Union Bankshares first reported a position in ImmunityBio in Q2 2025 and has held it in 5 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Atlantic Union Bankshares's 13F filing for Q2 2026, filed 11 Aug 2026.